Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer

Clinical trial NCT06877299 · RECRUITING

Trial details

NCT number: NCT06877299
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Lung Cancer

Start date: 2025-07-04
Primary completion: 2027-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.